Avis Budget Group, Inc. (NASDAQ:CAR) shares increased 8.56% in last trading session and ended the day at $27.52. CAR Gross Margin is 49.80% and its has a return on assets of 1.80%. Avis Budget Group, Inc. (NASDAQ:CAR) quarterly performance is -44.73%.
Avis Budget Group, Inc. (NASDAQ: CAR) announced that it has entered into a cooperation agreement with SRS Investment Management, the Company’s largest stockholder for the last several years, under which Brian Choi, a designee of SRS, will be appointed to the Avis Budget Group Board of Directors. Avis Budget Group also announced that the Board has increased the Company’s share repurchase authorization by $300 million.
Cullen/Frost Bankers, Inc. (NYSE:CFR) ended the last trading day at $43.83. Company weekly volatility is calculated as 4.25% and price to cash ratio as 0.72. Cullen/Frost Bankers, Inc. (NYSE:CFR) showed a weekly performance of -5.38%.
Cullen/Frost Bankers, Inc. (NYSE:CFR) reported that its provision for loan losses is expected to be $34.0 million in the fourth quarter 2015. Cullen/Frost Chairman and CEO Dick Evans attributed the action to the ongoing downturn in the energy space. The company will provide additional details next week when it announces earnings.
On 26 January, Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) shares moved up 0.18% and was closed at $4.11. LOAN EPS growth in last 5 year was 32.90%. Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) year to date (YTD) performance is -6.44%.
Dynavax Technologies Corporation (NASDAQ:DVAX) shares moved down -0.95% in last trading session and ended the day at $26.06. DVAX has a return on assets of -68.30%. Dynavax Technologies Corporation (NASDAQ:DVAX) quarterly performance is 13.30%.
On 19 January, Dynavax Technologies Corporation (NASDAQ:DVAX) announced that the Company and AstraZeneca signed an amendment to their existing Research Collaboration and License Agreement under which, based on the strategic priorities of the two companies, AstraZeneca will now conduct a Phase 2a safety and efficacy trial of AZD1419 in asthma patients that was originally to be conducted by Dynavax.
Energy Transfer Equity, L.P. (NYSE:ETE) caters to the Basic Materials space. It has a net profit margin of 2.10% and weekly performance is 31.30%. On the last day of trading company shares ended up at $9.90. Energy Transfer Equity, L.P. (NYSE:ETE) distance from 50-day simple moving average (SMA50) is -29.55%.
Energy Transfer Equity LP (NYSE:ETE) was downgraded by Zacks Investment Research from a “buy” rating to a “strong sell” rating in a research report issued on Wednesday, ARN reports.
Leave a Reply